{"id":4477,"date":"2025-11-29T07:54:17","date_gmt":"2025-11-29T07:54:17","guid":{"rendered":"https:\/\/novumlab.eu\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/"},"modified":"2026-01-21T09:59:57","modified_gmt":"2026-01-21T09:59:57","slug":"retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro","status":"publish","type":"post","link":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/","title":{"rendered":"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &#038; Mounjaro"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &amp; Mounjaro<\/h1>\n\n<p>Just when we thought weight loss peptides couldn&#8217;t get more effective, <strong>Retatrutide<\/strong> entered the scene. This groundbreaking triple-agonist peptide is showing weight loss results that rival bariatric surgery \u2013 without going under the knife.<\/p>\n\n<p>In clinical trials, Retatrutide has demonstrated up to <strong>24% body weight reduction<\/strong>, surpassing both Semaglutide (Ozempic\/Wegovy) and Tirzepatide (Mounjaro\/Zepbound). But what makes this peptide so powerful? Let&#8217;s dive into the science.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">What is Retatrutide?<\/h2>\n\n<p><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide\/\">Retatrutide<\/a><\/strong> (also known as LY3437943) is a novel peptide developed by Eli Lilly that activates three different hormone receptors simultaneously:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>GLP-1<\/strong> (Glucagon-Like Peptide-1) \u2013 Suppresses appetite and slows gastric emptying<\/li>\n\n\n\n<li><strong>GIP<\/strong> (Glucose-Dependent Insulinotropic Polypeptide) \u2013 Enhances insulin secretion and fat metabolism<\/li>\n\n\n\n<li><strong>Glucagon<\/strong> \u2013 Increases energy expenditure and fat burning<\/li>\n<\/ul>\n\n<p>This &#8222;triple-agonist&#8220; approach attacks obesity from multiple angles \u2013 reducing how much you eat while simultaneously increasing how many calories you burn. It&#8217;s a combination that previous weight loss drugs couldn&#8217;t achieve.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">How Retatrutide Compares: The Gewichtsverlust Hierarchy<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Peptide<\/th><th>Mechanism<\/th><th>Average Weight Loss<\/th><th>Max Weight Loss<\/th><\/tr><\/thead><tbody><tr><td><a href=\"https:\/\/novumlab.eu\/de\/produkt\/liraglutide\/\">Liraglutide<\/a><\/td><td>GLP-1 only<\/td><td>5-8%<\/td><td>~10%<\/td><\/tr><tr><td><a href=\"https:\/\/novumlab.eu\/de\/produkt\/semaglutide\/\">Semaglutide<\/a><\/td><td>GLP-1 only (enhanced)<\/td><td>10-15%<\/td><td>~20%<\/td><\/tr><tr><td><a href=\"https:\/\/novumlab.eu\/de\/produkt\/tirzepatide\/\">Tirzepatide<\/a><\/td><td>GLP-1 + GIP (dual)<\/td><td>15-21%<\/td><td>~25%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide\/\">Retatrutide<\/a><\/strong><\/td><td><strong>GLP-1 + GIP + Glucagon (triple)<\/strong><\/td><td><strong>17-24%<\/strong><\/td><td><strong>~28%+<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>As you can see, each generation of weight loss peptides has improved upon the last. Retatrutide represents the cutting edge of this evolution.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">The Science: How Retatrutide Works<\/h2>\n\n<h3 class=\"wp-block-heading\">\ud83c\udfaf GLP-1 Receptor Activation<\/h3>\n\n<p>Like Semaglutide and Tirzepatide, Retatrutide activates GLP-1 receptors to:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Dramatically reduce appetite and food cravings<\/li>\n\n\n\n<li>Slow gastric emptying (food stays in stomach longer)<\/li>\n\n\n\n<li>Enhance glucose-dependent insulin secretion<\/li>\n\n\n\n<li>Promote satiety signals in the brain<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">\ud83c\udfaf GIP Receptor Activation<\/h3>\n\n<p>GIP activation (shared with Tirzepatide) adds:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Improved insulin sensitivity<\/li>\n\n\n\n<li>Enhanced fat metabolism<\/li>\n\n\n\n<li>Better nutrient partitioning<\/li>\n\n\n\n<li>Synergistic effects with GLP-1<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">\ud83d\udd25 Glucagon Receptor Activation (The Game-Changer)<\/h3>\n\n<p>This is what sets Retatrutide apart. Glucagon activation provides:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Increased Energy Expenditure<\/strong> \u2013 Your body burns more calories at rest<\/li>\n\n\n\n<li><strong>Enhanced Thermogenesis<\/strong> \u2013 Directly stimulates fat burning<\/li>\n\n\n\n<li><strong>Liver Fat Reduction<\/strong> \u2013 Particularly effective for NAFLD\/fatty liver<\/li>\n\n\n\n<li><strong>Ketone Production<\/strong> \u2013 Promotes metabolic flexibility<\/li>\n<\/ul>\n\n<p>While GLP-1 and GIP primarily work by making you eat less, glucagon makes you burn more. This dual approach \u2013 eat less AND burn more \u2013 explains Retatrutide&#8217;s superior results.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Clinical Trial Results: The Numbers Don&#8217;t Lie<\/h2>\n\n<p>The Phase 2 clinical trial of Retatrutide (published in the New England Journal of Medicine) produced jaw-dropping results:<\/p>\n\n<h3 class=\"wp-block-heading\">Gewichtsverlust at 48 Weeks:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li><strong>4mg dose:<\/strong> 17.5% average body weight loss<\/li>\n\n\n\n<li><strong>8mg dose:<\/strong> 22.8% average body weight loss<\/li>\n\n\n\n<li><strong>12mg dose:<\/strong> 24.2% average body weight loss<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Impressive Responder Rates:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>Over <strong>90%<\/strong> of participants lost at least 5% body weight<\/li>\n\n\n\n<li>Over <strong>75%<\/strong> lost at least 15% body weight<\/li>\n\n\n\n<li>Over <strong>50%<\/strong> achieved 20% or greater weight loss<\/li>\n\n\n\n<li>Some participants lost <strong>over 28%<\/strong> of their body weight<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Metabolic Improvements:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>Significant reductions in HbA1c (blood sugar control)<\/li>\n\n\n\n<li>Improved cholesterol profiles<\/li>\n\n\n\n<li>Reduced liver fat (important for fatty liver disease)<\/li>\n\n\n\n<li>Lower blood pressure<\/li>\n<\/ul>\n\n<p>To put this in perspective: a 200-pound person could potentially lose 48+ pounds on Retatrutide \u2013 approaching results typically only seen with bariatric surgery.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Retatrutide vs. Tirzepatide: Which is Better?<\/h2>\n\n<p>Both are excellent options, but they have key differences:<\/p>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Tirzepatide<\/th><th>Retatrutide<\/th><\/tr><\/thead><tbody><tr><td><strong>Mechanism<\/strong><\/td><td>Dual (GLP-1 + GIP)<\/td><td>Triple (GLP-1 + GIP + Glucagon)<\/td><\/tr><tr><td><strong>Weight Loss<\/strong><\/td><td>15-21%<\/td><td>17-24%<\/td><\/tr><tr><td><strong>Energy Expenditure<\/strong><\/td><td>Minimal increase<\/td><td>Significant increase<\/td><\/tr><tr><td><strong>Liver Fat Reduction<\/strong><\/td><td>Moderate<\/td><td>Substantial<\/td><\/tr><tr><td><strong>FDA Status<\/strong><\/td><td>Approved<\/td><td>Phase 3 trials ongoing<\/td><\/tr><tr><td><strong>Research Data<\/strong><\/td><td>Extensive<\/td><td>Growing (Phase 2 complete)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<h3 class=\"wp-block-heading\">Choose Tirzepatide If:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>You want an FDA-approved option with more long-term safety data<\/li>\n\n\n\n<li>15-20% weight loss would meet your goals<\/li>\n\n\n\n<li>You prefer a more established compound<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Choose Retatrutide If:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>You want maximum possible weight loss<\/li>\n\n\n\n<li>You have fatty liver disease (NAFLD\/NASH)<\/li>\n\n\n\n<li>Previous GLP-1s haven&#8217;t provided enough results<\/li>\n\n\n\n<li>You want the thermogenic\/fat-burning benefits of glucagon activation<\/li>\n<\/ul>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Retatrutide Dosage Information<\/h2>\n\n<p>Based on clinical trial protocols, Retatrutide is administered via once-weekly subcutaneous injection with gradual dose escalation:<\/p>\n\n<h3 class=\"wp-block-heading\">Typical Titration Schedule:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li><strong>Weeks 1-4:<\/strong> Starting dose (lowest)<\/li>\n\n\n\n<li><strong>Weeks 5-8:<\/strong> Increase to medium dose<\/li>\n\n\n\n<li><strong>Weeks 9-12:<\/strong> Increase to target dose<\/li>\n\n\n\n<li><strong>Week 12+:<\/strong> Maintenance at target dose<\/li>\n<\/ul>\n\n<p>Gradual titration is crucial for minimizing side effects, particularly GI symptoms. Rushing to higher doses erh\u00f6ht nausea and discomfort.<\/p>\n\n<p><strong>Available at NovumLab:<\/strong> <a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide\/\">Retatrutide<\/a> in multiple dosages: 5mg, 10mg, 12mg, 15mg, 20mg, 22mg, 30mg, 40mg, 50mg, and 60mg.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Side Effects &amp; Safety Profile<\/h2>\n\n<p>Retatrutide&#8217;s side effect profile is similar to other GLP-1 agonists, primarily gastrointestinal:<\/p>\n\n<h3 class=\"wp-block-heading\">Common Side Effects:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li><strong>Nausea<\/strong> \u2013 Most common, usually decreases over time<\/li>\n\n\n\n<li><strong>Diarrhea<\/strong> \u2013 Often dose-related<\/li>\n\n\n\n<li><strong>Vomiting<\/strong> \u2013 Less common than nausea<\/li>\n\n\n\n<li><strong>Constipation<\/strong> \u2013 Some users experience this instead of diarrhea<\/li>\n\n\n\n<li><strong>Decreased appetite<\/strong> \u2013 Expected and generally desired<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Managing Side Effects:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>Start with the lowest dose and titrate slowly<\/li>\n\n\n\n<li>Eat smaller, more frequent meals<\/li>\n\n\n\n<li>Avoid high-fat foods (can worsen nausea)<\/li>\n\n\n\n<li>Stay well hydrated<\/li>\n\n\n\n<li>Consider anti-nausea remedies (ginger, peppermint)<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Considerations:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>Not recommended for those with personal\/family history of medullary thyroid cancer<\/li>\n\n\n\n<li>Caution in patients with pancreatitis history<\/li>\n\n\n\n<li>Monitor for gallbladder issues during rapid weight loss<\/li>\n<\/ul>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Combining Retatrutide with Other Peptides<\/h2>\n\n<p>Some users combine Retatrutide with complementary peptides for verbessert results:<\/p>\n\n<h3 class=\"wp-block-heading\">For Body Recomposition:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/cjc-1295-ipamorelin-kombination\/\">CJC-1295 + Ipamorelin<\/a><\/strong> \u2013 Support growth hormone for muscle preservation during weight loss<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/tesamorelin\/\">Tesamorelin<\/a><\/strong> \u2013 Additional visceral fat reduction<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">For Recovery &amp; Healing:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/bpc-157\/\">BPC-157<\/a><\/strong> \u2013 Gut health support (GLP-1s can stress the GI system)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/tb-500-thymosin-beta-4\/\">TB-500<\/a><\/strong> \u2013 Tissue repair and recovery<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Advanced Gewichtsverlust Stack:<\/h3>\n\n<p>For those seeking maximum results, some combine Retatrutide with:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/cagrilintide\/\">Cagrilintide<\/a><\/strong> \u2013 Amylin analog for additional appetite suppression<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/5-amino-1mq\/\">5-Amino-1MQ<\/a><\/strong> \u2013 NNMT inhibitor for metabolic enhancement<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/aod-9604\/\">AOD-9604<\/a><\/strong> \u2013 Targeted fat metabolism<\/li>\n<\/ul>\n\n<p>NovumLab also offers <a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide-cagrilintide-blend\/\">Retatrutide + Cagrilintide Blend<\/a> for those seeking quad-pathway weight loss action.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">The Future of Gewichtsverlust: What&#8217;s Coming?<\/h2>\n\n<p>Retatrutide represents the current frontier, but research continues:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Quad-agonists<\/strong> \u2013 Adding amylin receptor activation to triple-agonists<\/li>\n\n\n\n<li><strong>Oral formulations<\/strong> \u2013 Moving away from injections<\/li>\n\n\n\n<li><strong>Long-acting versions<\/strong> \u2013 Monthly instead of weekly dosing<\/li>\n\n\n\n<li><strong>Combination therapies<\/strong> \u2013 Peptides paired with other mechanisms<\/li>\n<\/ul>\n\n<p>The trajectory is clear: each new generation of weight loss peptides verbessert on the last. Retatrutide is today&#8217;s gold standard, but even more effective options are on the horizon.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n<h3 class=\"wp-block-heading\">When will Retatrutide be FDA approved?<\/h3>\n\n<p>Retatrutide is currently in Phase 3 clinical trials. If successful, FDA approval could come in 2025-2026. Until then, it&#8217;s available for research purposes.<\/p>\n\n<h3 class=\"wp-block-heading\">Is Retatrutide stronger than Tirzepatide?<\/h3>\n\n<p>Yes, clinical data shows Retatrutide produces approximately 3-5% greater weight loss than Tirzepatide, primarily due to the added glucagon receptor activation increasing energy expenditure.<\/p>\n\n<h3 class=\"wp-block-heading\">Can I switch from Semaglutide\/Tirzepatide to Retatrutide?<\/h3>\n\n<p>Yes, many people transition from earlier GLP-1s to Retatrutide for verbessert results. Consult with a healthcare provider for appropriate transition protocols.<\/p>\n\n<h3 class=\"wp-block-heading\">How long until I see results?<\/h3>\n\n<p>Appetite reduction typically occurs within the first week. Noticeable weight loss usually begins within 4-6 weeks. Maximum results are seen at 6-12 months of consistent use.<\/p>\n\n<h3 class=\"wp-block-heading\">Will I regain weight after stopping?<\/h3>\n\n<p>Like all weight loss medications, some weight regain is common after discontinuation. Establishing healthy eating and exercise habits during treatment is crucial for maintaining results.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<h2 class=\"wp-block-heading\">Conclusion: Is Retatrutide Worth It?<\/h2>\n\n<p><strong><a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide\/\">Retatrutide<\/a><\/strong> represents the most advanced weight loss peptide currently available. Its triple-agonist mechanism delivers unparalleled results by attacking obesity from multiple angles \u2013 reducing appetite, improving metabolism, AND increasing energy expenditure.<\/p>\n\n<p>For those who have plateaued on Semaglutide or Tirzepatide, or anyone seeking maximum weight loss potential, Retatrutide offers a compelling next step. While it awaits FDA approval, the clinical data speaks for itself: this peptide is changing what&#8217;s possible in medical weight management.<\/p>\n\n<p><strong>Ready to explore the next generation of weight loss?<\/strong> Browse our complete selection of <a href=\"https:\/\/novumlab.eu\/product-category\/fat-loss-weight-management\/\">weight loss peptides<\/a> at NovumLab, including <a href=\"https:\/\/novumlab.eu\/de\/produkt\/retatrutide\/\">Retatrutide<\/a>, <a href=\"https:\/\/novumlab.eu\/de\/produkt\/tirzepatide\/\">Tirzepatide<\/a>, and <a href=\"https:\/\/novumlab.eu\/de\/produkt\/semaglutide\/\">Semaglutide<\/a>.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<p><em>Disclaimer: This article is for educational and informational purposes only. Retatrutide is an investigational compound not yet approved for human therapeutic use. Peptides are sold for research purposes. Always consult with a healthcare professional before starting any new protocol.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &amp; Mounjaro Just when we thought weight loss peptides couldn&#8217;t get more effective,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[1156],"tags":[],"class_list":["post-4477","post","type-post","status-publish","format-standard","hentry","category-nicht-kategorisiert"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Retatrutide: The Triple-Agonist Peptide That&#039;s Outperforming Ozempic &amp; Mounjaro - NovumLab.eu<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retatrutide: The Triple-Agonist Peptide That&#039;s Outperforming Ozempic &amp; Mounjaro - NovumLab.eu\" \/>\n<meta property=\"og:description\" content=\"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &amp; Mounjaro Just when we thought weight loss peptides couldn&#8217;t get more effective,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/\" \/>\n<meta property=\"og:site_name\" content=\"NovumLab.eu\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-29T07:54:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-21T09:59:57+00:00\" \/>\n<meta name=\"author\" content=\"Kevin Wojtas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Wojtas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/\"},\"author\":{\"name\":\"Kevin Wojtas\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#\\\/schema\\\/person\\\/bd9b8a6e910d9045da273f398bfbf7b4\"},\"headline\":\"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &#038; Mounjaro\",\"datePublished\":\"2025-11-29T07:54:17+00:00\",\"dateModified\":\"2026-01-21T09:59:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/\"},\"wordCount\":1250,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#organization\"},\"articleSection\":[\"Nicht kategorisiert\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/\",\"url\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/\",\"name\":\"Retatrutide: The Triple-Agonist Peptide That's Outperforming Ozempic & Mounjaro - NovumLab.eu\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#website\"},\"datePublished\":\"2025-11-29T07:54:17+00:00\",\"dateModified\":\"2026-01-21T09:59:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &#038; Mounjaro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/\",\"name\":\"Buy Premium Peptides Online | BPC-157, Semaglutide, CJC-1295, TB-500 | Lab-Tested EU Store\",\"description\":\"Premium-Peptide online kaufen | BPC-157, GHK-CU, CJC-1295, TB-500 | Laborgepr\u00fcfter EU-Shop\",\"publisher\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#organization\",\"name\":\"NovumLab.eu\",\"url\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/novumlab.eu\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo-scaled.png\",\"contentUrl\":\"https:\\\/\\\/novumlab.eu\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo-scaled.png\",\"width\":2560,\"height\":688,\"caption\":\"NovumLab.eu\"},\"image\":{\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/#\\\/schema\\\/person\\\/bd9b8a6e910d9045da273f398bfbf7b4\",\"name\":\"Kevin Wojtas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g\",\"caption\":\"Kevin Wojtas\"},\"sameAs\":[\"https:\\\/\\\/novumlab.eu\"],\"url\":\"https:\\\/\\\/novumlab.eu\\\/de\\\/author\\\/infonovumlab-eu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Retatrutide: The Triple-Agonist Peptide That's Outperforming Ozempic & Mounjaro - NovumLab.eu","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/","og_locale":"de_DE","og_type":"article","og_title":"Retatrutide: The Triple-Agonist Peptide That's Outperforming Ozempic & Mounjaro - NovumLab.eu","og_description":"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &amp; Mounjaro Just when we thought weight loss peptides couldn&#8217;t get more effective,","og_url":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/","og_site_name":"NovumLab.eu","article_published_time":"2025-11-29T07:54:17+00:00","article_modified_time":"2026-01-21T09:59:57+00:00","author":"Kevin Wojtas","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Kevin Wojtas","Gesch\u00e4tzte Lesezeit":"6 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/#article","isPartOf":{"@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/"},"author":{"name":"Kevin Wojtas","@id":"https:\/\/novumlab.eu\/de\/#\/schema\/person\/bd9b8a6e910d9045da273f398bfbf7b4"},"headline":"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &#038; Mounjaro","datePublished":"2025-11-29T07:54:17+00:00","dateModified":"2026-01-21T09:59:57+00:00","mainEntityOfPage":{"@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/"},"wordCount":1250,"commentCount":0,"publisher":{"@id":"https:\/\/novumlab.eu\/de\/#organization"},"articleSection":["Nicht kategorisiert"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/","url":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/","name":"Retatrutide: The Triple-Agonist Peptide That's Outperforming Ozempic & Mounjaro - NovumLab.eu","isPartOf":{"@id":"https:\/\/novumlab.eu\/de\/#website"},"datePublished":"2025-11-29T07:54:17+00:00","dateModified":"2026-01-21T09:59:57+00:00","breadcrumb":{"@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novumlab.eu\/de\/retatrutide-the-triple-agonist-peptide-thats-outperforming-ozempic-mounjaro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/novumlab.eu\/de\/home\/"},{"@type":"ListItem","position":2,"name":"Retatrutide: The Triple-Agonist Peptide That&#8217;s Outperforming Ozempic &#038; Mounjaro"}]},{"@type":"WebSite","@id":"https:\/\/novumlab.eu\/de\/#website","url":"https:\/\/novumlab.eu\/de\/","name":"Buy Premium Peptides Online | BPC-157, Semaglutide, CJC-1295, TB-500 | Lab-Tested EU Store","description":"Premium-Peptide online kaufen | BPC-157, GHK-CU, CJC-1295, TB-500 | Laborgepr\u00fcfter EU-Shop","publisher":{"@id":"https:\/\/novumlab.eu\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/novumlab.eu\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/novumlab.eu\/de\/#organization","name":"NovumLab.eu","url":"https:\/\/novumlab.eu\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/novumlab.eu\/de\/#\/schema\/logo\/image\/","url":"https:\/\/novumlab.eu\/wp-content\/uploads\/2025\/11\/Logo-scaled.png","contentUrl":"https:\/\/novumlab.eu\/wp-content\/uploads\/2025\/11\/Logo-scaled.png","width":2560,"height":688,"caption":"NovumLab.eu"},"image":{"@id":"https:\/\/novumlab.eu\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/novumlab.eu\/de\/#\/schema\/person\/bd9b8a6e910d9045da273f398bfbf7b4","name":"Kevin Wojtas","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e673f0378777fc4f35c0b73edf6e2e6ca6bce4ad9e5c158337265a89f3968a69?s=96&d=mm&r=g","caption":"Kevin Wojtas"},"sameAs":["https:\/\/novumlab.eu"],"url":"https:\/\/novumlab.eu\/de\/author\/infonovumlab-eu\/"}]}},"_links":{"self":[{"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/posts\/4477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/comments?post=4477"}],"version-history":[{"count":5,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/posts\/4477\/revisions"}],"predecessor-version":[{"id":4680,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/posts\/4477\/revisions\/4680"}],"wp:attachment":[{"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/media?parent=4477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/categories?post=4477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/novumlab.eu\/de\/wp-json\/wp\/v2\/tags?post=4477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}